Abstract:Background Polycystic ovary syndrome (PCOS) seriously affects the fertility and health of women of childbearing age. We look forward to finding potential biomarkers for PCOS that can aid clinical diagnosis. Methods We acquired PCOS and normal granulosa cell (GC) expression profiles from the Gene Expression Omnibus (GEO) database. After data preprocessing, differentially expressed genes (DEGs) were screened by limma package, and Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis and Gene Set Enrichment Analysis (GSEA) were performed. Recursive feature elimination (RFE) algorithm and the least absolute shrinkage and selection operator (LASSO) Cox regression analysis were used to acquire feature genes as potential biomarkers. Time-dependent receiver operator characteristic curve (ROC curve) and Confusion matrix were used to verify the classification performance of biomarkers. Then, the expression characteristics of biomarkers in PCOS and normal cells were analyzed, and the insulin resistance (IR) score of samples was computed by ssGSEA. Immune characterization of biomarkers was evaluated using MCP counter and single sample gene set enrichment analysis (ssGSEA). Finally, the correlation between biomarkers and the scores of each pathway was assessed. Results We acquired 93 DEGs, and the enrichment results indicated that most of DEGs in PCOS group were significantly enriched in immune-related biological pathways. Further screening results indicated that JDP2 and HMOX1 were potential biomarkers. The area under ROC curve (AUC) value and Confusion matrix of the two biomarkers were ideal when separated and combined. In the combination, the training set AUC = 0.929 and the test set AUC = 0.917 indicated good diagnostic performance of the two biomarkers. Both biomarkers were highly expressed in the PCOS group, and both biomarkers, which should be suppressed in the preovulation phase, were elevated in PCOS tissues. The IR score of PCOS group was higher, and the expression of JDP2 and HMOX1 showed a significant positive correlation with IR score. Most immune cell scores and immune infiltration results were significantly higher in PCOS. Comprehensive analysis indicated that the two biomarkers had strong correlation with immune-related pathways. Conclusion We acquired two potential biomarkers, JDP2 and HMOX1. We found that they were highly expressed in the PCOS and had a strong positive correlation with immune-related pathways.

Identification of Immune-Associated Genes in Diagnosing Polycystic Ovary Syndrome with Metabolic Syndrome by Weighted Gene Co-expression Network Analysis

Identification and validation of core genes associated with polycystic ovary syndrome and metabolic syndrome

Elucidating the Role of Autophagy-related Genes in Polycystic Ovary Syndrome: Implications for Diagnostic Models and Immune Response Regulation

Screening of potential biomarkers for polycystic ovary syndrome and identification of expression and immune characteristics

Cross-talk between oxidative stress and lipid metabolism regulators reveals molecular clusters and immunological characterization in polycystic ovarian syndrome

Identification of potential diagnostic genes for atherosclerosis in women with polycystic ovary syndrome

Identification of the Hub Genes in Polycystic Ovary Syndrome Based on Disease‐associated Molecule Network

Identification of key biomarkers for predicting atherosclerosis progression in polycystic ovary syndrome via bioinformatics analysis and machine learning

Identification of the Shared Gene Signatures and Pathways Between Polycystic Ovary Syndrome and Endometrial Cancer: an Omics Data Based Combined Approach.

Identification of CCR7 As a Potential Biomarker in Polycystic Ovary Syndrome Through Transcriptome Sequencing and Integrated Bioinformatics

Investigating the Role of Inflammatory Response in Polycystic Ovary Syndrome Using Integrated RNA-Seq Analysis

Prediction of Shared Gene Signatures and Biological Mechanisms Between Polycystic Ovary Syndrome and Asthma: Based on Weighted Gene Coexpression Network Analysis.

Identification of the role of immune-related genes in the diagnosis of bipolar disorder with metabolic syndrome through machine learning and comprehensive bioinformatics analysis

Bioinformatics-based analysis of potential therapeutic target genes for polycystic ovary syndrome

Transcriptome Profiling Revealed the Relationship Between Immune-Related Genes and M6a Modifiers in Polycystic Ovary Syndrome

Discovery of immune-related diagnostic biomarkers and construction of diagnostic model in varies polycystic ovary syndrome

Unraveling the pathogenic interplay between SARS-CoV-2 and polycystic ovary syndrome using bioinformatics and experimental validation

Identification of Potential Biomarkers of Polycystic Ovary Syndrome Via Integrated Bioinformatics Analysis

How to Screen and Prevent Metabolic Syndrome in Patients of PCOS Early: Implications From Metabolomics

Integrated Transcriptome Analysis of Lncrna, Mirna, and Mrna Reveals Key Regulatory Modules for Polycystic Ovary Syndrome

Development of an Endoplasmic Reticulum Stress-Related Diagnostic Signature in Polycystic Ovary Syndrome